Sepio Capital LP raised its position in Abbott Laboratories (NYSE:ABT - Free Report) by 296.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 786,102 shares of the healthcare product maker's stock